Pentobarbital sodium inhibits calcium uptake in vascular smooth muscle.
This report demonstrates that the commonly used anesthetic agent, pentobarbital sodium, in concentrations of 1 . 10(-4) to 2 . 10(-3) M inhibits calcium (Ca2+) uptake in both rat aortic and portal venous smooth muscle. The data indicate that total exchangeable Ca2+ in portal vein is reduced by about 15% in 1 . 10(-4) M pentobarbital sodium, while the intracellular exchangeable Ca2+ is reduced by 24%. On the other hand, in aortic smooth muscle, while 5--20 . 10(-4) M pentobarbital sodium reduces total exchangeable Ca2+ by about 15%, intracellular Ca2+ is reduced by 22% in 5 . 10(-4) M pentobarbital sodium and by 38% in 2 . 10(-3) M pentobarbital sodium. The present studies thus reveal that concentrations of pentobarbital sodium known to be present during induction of surgical anesthesia can exert significant inhibitory effects on exchangeability and transmembrane movement of Ca2+ in at least two different types of blood vessels.
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000378:metabolism; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D010424:Pentobarbital / Q000494:pharmacology*; D011169:Portal Vein / Q000187:drug effects / Q000378:metabolism; D051381:Rats
D010424:Pentobarbital; D002118:Calcium